Medico Remedies Hits 52-Week Low, Underperforms Sector and Sensex
Medico Remedies, a microcap pharmaceutical company, has hit a 52-week low in its stock price on May 14, 2024, according to MarketsMojo. The stock has fallen to Rs.38.86, underperforming the sector by -1.66%. It has also been trading below its moving averages, indicating a downward trend. Compared to the Sensex, Medico Remedies has seen a decline of -52.93% in the past year, potentially facing challenges in the current market conditions.
Medico Remedies, a microcap pharmaceutical company, has recently hit a 52-week low in its stock price on May 14, 2024. This news has been confirmed by MarketsMOJO, who have given a "Sell" call for the stock.
The stock price of Medico Remedies has fallen to Rs.38.86, which is its lowest point in the past year. Today's performance has also been underwhelming, with the stock underperforming the sector by -1.66%. This is the second consecutive day of losses for the company, with a total decline of -6.24% in this period.
In terms of moving averages, Medico Remedies is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day averages. This indicates a downward trend in the stock's performance.
Compared to the overall performance of the Sensex, Medico Remedies has not fared well in the past year, with a decline of -52.93% while the Sensex has seen a growth of 17.38%.
As a microcap company in the pharmaceutical industry, Medico Remedies may face challenges in the current market conditions. Investors should carefully consider their options before making any decisions regarding this stock.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
